Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 2
1949 3
1951 2
1952 2
1953 1
1957 1
1959 1
1962 1
1963 1
1965 1
1966 1
1968 1
1969 1
1971 1
1972 2
1973 3
1974 1
1975 1
1976 3
1977 2
1978 5
1979 5
1980 4
1981 2
1982 2
1983 3
1984 3
1985 3
1986 6
1987 5
1988 7
1989 3
1990 4
1991 5
1992 6
1993 3
1994 4
1995 4
1996 4
1997 9
1998 4
1999 12
2000 17
2001 11
2002 14
2003 15
2004 17
2005 12
2006 13
2007 15
2008 16
2009 17
2010 16
2011 13
2012 23
2013 26
2014 24
2015 32
2016 29
2017 30
2018 19
2019 27
2020 32
2021 35
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

555 results
Results by year
Filters applied: . Clear all
Page 1
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Feagan BG, Danese S, Loftus EV Jr, Vermeire S, Schreiber S, Ritter T, Fogel R, Mehta R, Nijhawan S, Kempiński R, Filip R, Hospodarskyy I, Seidler U, Seibold F, Beales ILP, Kim HJ, McNally J, Yun C, Zhao S, Liu X, Hsueh CH, Tasset C, Besuyen R, Watanabe M, Sandborn WJ, Rogler G, Hibi T, Peyrin-Biroulet L. Feagan BG, et al. Among authors: mcnally j. Lancet. 2021 Jun 19;397(10292):2372-2384. doi: 10.1016/S0140-6736(21)00666-8. Epub 2021 Jun 3. Lancet. 2021. PMID: 34090625 Clinical Trial.
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays).
Corsaro B, Yang TY, Murphy R, Sonderegger I, Exley A, Bertholet S, Dakappagari N, Dessy F, Garofolo F, Kierstead L, Koch H, Sarikonda G, Savoie N, Siggers R, Solstad T, Lu Y, Milton M, Marshall JC, DelCarpini J, Gorovits B, Gupta S, Jesaitis L, Kamerud J, Kromminga A, Ma A, McNally J, Yan H, Wu B, Verthelyi D, Kirshner S, Pedras-Vasconcelos J, Rajadhyaksha M, Staack RF, Cherry E, Cludts I, Dahlbäck M, Gunn GR, Ishii-Watabe A, Jawa V, Kubiak R, Partridge M, Petrillo M, Pine SO, Poetzl J, Song S, Stebbins C, Wu Y, Zhang L, Kar S, Liang M, Abhari MR, Schweighardt B, Stubenrauch K, Xu Y. Corsaro B, et al. Among authors: mcnally j. Bioanalysis. 2021 Mar;13(6):415-463. doi: 10.4155/bio-2021-0007. Epub 2021 Feb 3. Bioanalysis. 2021. PMID: 33533276 Free article.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
Feld JJ, Jacobson IM, Hézode C, Asselah T, Ruane PJ, Gruener N, Abergel A, Mangia A, Lai CL, Chan HL, Mazzotta F, Moreno C, Yoshida E, Shafran SD, Towner WJ, Tran TT, McNally J, Osinusi A, Svarovskaia E, Zhu Y, Brainard DM, McHutchison JG, Agarwal K, Zeuzem S; ASTRAL-1 Investigators. Feld JJ, et al. Among authors: mcnally j. N Engl J Med. 2015 Dec 31;373(27):2599-607. doi: 10.1056/NEJMoa1512610. Epub 2015 Nov 16. N Engl J Med. 2015. PMID: 26571066 Free article. Clinical Trial.
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62).
Piccoli S, Mehta D, Vitaliti A, Allinson J, Amur S, Eck S, Green C, Hedrick M, Hopper S, Ji A, Joyce A, Litwin V, Maher K, Mathews J, Peng K, Safavi A, Wang YM, Zhang Y, Amaravadi L, Palackal N, Thankamony S, Beaver C, Bame E, Emrich T, Grimaldi C, Haulenbeek J, Joyce A, Kakkanaiah V, Lanham D, Maher K, Mayer A, Trampont PC, Vermet L, Dakappagari N, Fleener C, Garofolo F, Rogers C, Tangri S, Xu Y, Liang M, Rajadhyaksha M, Richards S, Schweighardt B, Purushothama S, Baltrukonis D, Brumm J, Cherry E, Delcarpini J, Gleason C, Kirshner S, Kubiak R, Pan L, Partridge M, Pedras-Vasconcelos J, Qu Q, Skibeli V, Saunders TS, Staack RF, Stubenrauch K, Torri A, Verthelyi D, Yan H, Gorovits B, Palmer R, Milton M, Long B, Corsaro B, Farrokhi V, Fiscella M, Henderson N, Jawa V, McNally J, Murphy R, Waldner H, Yang TY. Piccoli S, et al. Among authors: mcnally j. Bioanalysis. 2019 Dec;11(24):2207-2244. doi: 10.4155/bio-2019-0271. Epub 2019 Dec 10. Bioanalysis. 2019. PMID: 31820675 Free article.
Transcription dynamics.
Hager GL, McNally JG, Misteli T. Hager GL, et al. Among authors: mcnally jg. Mol Cell. 2009 Sep 24;35(6):741-53. doi: 10.1016/j.molcel.2009.09.005. Mol Cell. 2009. PMID: 19782025 Free PMC article. Review.
MR Angiography Series: Neurovascular MR Angiography.
Costello J, Alexander MD, McNally JS, Hecht EM, Porambo ME, Lau VC, DeMarco JK. Costello J, et al. Among authors: mcnally js. Radiographics. 2021 Nov-Dec;41(7):E204-E205. doi: 10.1148/rg.2021210180. Radiographics. 2021. PMID: 34723690
Chlamydia pecorum-Associated Sporadic Ovine Abortion.
Westermann T, Jenkins C, Onizawa E, Gestier S, McNally J, Kirkland P, Zhang J, Bogema D, Manning LK, Walker K, Pinczowski P. Westermann T, et al. Among authors: mcnally j. Vet Pathol. 2021 Jan;58(1):114-122. doi: 10.1177/0300985820967451. Epub 2020 Nov 18. Vet Pathol. 2021. PMID: 33205699
Hospice nursing.
McNally JC, Bohnet NL, Lindquist ME. McNally JC, et al. Semin Oncol Nurs. 1996 Aug;12(3):238-43. doi: 10.1016/s0749-2081(96)80042-8. Semin Oncol Nurs. 1996. PMID: 8857693 Review.
Transcription factories.
Rieder D, Trajanoski Z, McNally JG. Rieder D, et al. Among authors: mcnally jg. Front Genet. 2012 Oct 23;3:221. doi: 10.3389/fgene.2012.00221. eCollection 2012. Front Genet. 2012. PMID: 23109938 Free PMC article.
555 results